{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:48:28Z","timestamp":1792460908962,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.pcad.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T11:20:05Z","timestamp":1689074405000},"page":"80-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Insight into different phenotypic presentations of heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"79","author":[{"given":"Zubair","family":"Bashir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Tori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhairyasheel","family":"Ghosalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard P.","family":"Aurigemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.pcad.2023.07.003_bb0005","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke Statistics-2020 update: A report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pcad.2023.07.003_bb0010","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke Statistics-2019 update: A report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pcad.2023.07.003_bb0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"10.1016\/j.pcad.2023.07.003_bb0020","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.jacc.2018.08.2160","article-title":"Lifestyle modifications for preventing and treating heart failure","volume":"72","author":"Aggarwal","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0030","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11897-014-0219-3","article-title":"New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction","volume":"11","author":"Tschope","year":"2014","journal-title":"Curr Heart Fail Rep"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/heartjnl-2015-307787","article-title":"From comorbidities to heart failure with preserved ejection fraction: A story of oxidative stress","volume":"102","author":"Franssen","year":"2016","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.pcad.2023.07.003_bb0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","article-title":"Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction","volume":"4","author":"Franssen","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.pcad.2023.07.003_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ejhf.1741","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: A consensus recommendation from the heart failure association (HFA) of the European Society of Cardiology (ESC)","volume":"22","author":"Pieske","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"issue":"19","key":"10.1016\/j.pcad.2023.07.003_bb0060","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1161\/CIRCULATIONAHA.108.791681","article-title":"Determinants of left ventricular early-diastolic lengthening velocity: Independent contributions from left ventricular relaxation, restoring forces, and lengthening load","volume":"119","author":"Opdahl","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2023.07.003_bb0065","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCULATIONAHA.106.661983","article-title":"Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: A comparative Doppler-conductance catheterization study","volume":"116","author":"Kasner","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pcad.2023.07.003_bb0070","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","article-title":"Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction","volume":"57","author":"Kasner","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2023.07.003_bb0075","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ejhf.944","article-title":"Non-invasive estimation of left heart filling pressures: another nail in the coffin for E\/e'?","volume":"19","author":"Donal","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.pcad.2023.07.003_bb0080","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jacc.2016.12.037","article-title":"A test in context: E\/a and E\/e' to assess diastolic dysfunction and LV filling pressure","volume":"69","author":"Mitter","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.pcad.2023.07.003_bb0085","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: A community-based study","volume":"53","author":"Lam","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2023.07.003_bb0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jchf.2015.01.013","article-title":"Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction","volume":"3","author":"Al-Naamani","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pcad.2023.07.003_bb0095","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijcard.2016.11.154","article-title":"Modes of death in patients with heart failure and preserved ejection fraction","volume":"228","author":"Aschauer","year":"2017","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1540-8175.2011.01643.x","article-title":"Assessment of echocardiographic left atrial size: accuracy of M-mode and two-dimensional methods and prediction of diastolic dysfunction","volume":"29","author":"Stefano","year":"2012","journal-title":"Echocardiography"},{"issue":"9","key":"10.1016\/j.pcad.2023.07.003_bb0105","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1540-8175.2010.01216.x","article-title":"Indexed left atrial volume is a more sensitive indicator of filling pressures and left heart function than is anteroposterior left atrial diameter","volume":"27","author":"Moya-Mur","year":"2010","journal-title":"Echocardiography"},{"issue":"23","key":"10.1016\/j.pcad.2023.07.003_bb0110","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.jacc.2019.09.063","article-title":"Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction","volume":"74","author":"Shah","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2023.07.003_bb0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","article-title":"The transition from hypertension to heart failure: contemporary update","volume":"5","author":"Messerli","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.pcad.2023.07.003_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.110.979203","article-title":"Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community","volume":"124","author":"Lam","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pcad.2023.07.003_bb0125","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/hrt.2010.212787","article-title":"Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction","volume":"97","author":"Borlaug","year":"2011","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.pcad.2023.07.003_bb0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1291\/hypres.28.191","article-title":"Hypertensive heart disease","volume":"28","author":"Diamond","year":"2005","journal-title":"Hypertens Res"},{"issue":"10","key":"10.1016\/j.pcad.2023.07.003_bb0135","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00380-017-0995-2","article-title":"Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates","volume":"32","author":"Minatoguchi","year":"2017","journal-title":"Heart Vessel"},{"issue":"2","key":"10.1016\/j.pcad.2023.07.003_bb0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31083\/j.rcm.2020.02.65","article-title":"Clinical evaluation of infiltrative cardiomyopathies resulting in heart failure with preserved ejection fraction","volume":"21","author":"Madan","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.pcad.2023.07.003_bb0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac amyloidosis: Overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0150","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1002\/ehf2.13360","article-title":"Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy","volume":"8","author":"Devesa","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.pcad.2023.07.003_bb0155","first-page":"11","article-title":"Transthyretin cardiac amyloidosis in older adults: Optimizing cardiac imaging to the corresponding diagnostic and management goal","author":"Casta\u00f1o","year":"2017","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"9","key":"10.1016\/j.pcad.2023.07.003_bb0160","first-page":"1166.e1","article-title":"Wild-type transthyretin cardiac amyloidosis: Novel insights from advanced imaging","volume":"32","author":"Narotsky","year":"2016","journal-title":"Can J Cardiol"},{"issue":"19","key":"10.1016\/j.pcad.2023.07.003_bb0165","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0170","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.pcad.2023.07.003_bb0175","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy: An individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"17","key":"10.1016\/j.pcad.2023.07.003_bb0185","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/eurheartj\/ehq136","article-title":"Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy","volume":"31","author":"Melacini","year":"2010","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0190","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.amjcard.2011.03.083","article-title":"Comparison of prevalence, clinical course, and pathological findings of left ventricular systolic impairment versus normal systolic function in patients with hypertrophic cardiomyopathy","volume":"108","author":"Fernandez","year":"2011","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2023.07.003_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"issue":"25 Pt A","key":"10.1016\/j.pcad.2023.07.003_bb0200","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.jacc.2014.03.034","article-title":"Implications of coronary artery disease in heart failure with preserved ejection fraction","volume":"63","author":"Hwang","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.pcad.2023.07.003_bb0205","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","article-title":"Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"6","author":"Rush","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2023.07.003_bb0210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HCO.0b013e32833f0438","article-title":"Evolving focus on diastolic dysfunction in patients with coronary artery disease","volume":"25","author":"Ohara","year":"2010","journal-title":"Curr Opin Cardiol"},{"issue":"11","key":"10.1016\/j.pcad.2023.07.003_bb0215","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.amjcard.2009.02.010","article-title":"Left ventricular rotational mechanics in acute myocardial infarction and in chronic (ischemic and nonischemic) heart failure patients","volume":"103","author":"Bertini","year":"2009","journal-title":"Am J Cardiol"},{"issue":"17","key":"10.1016\/j.pcad.2023.07.003_bb0220","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jacc.2009.06.030","article-title":"Abnormal regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention: clinical significance of post-ischemic diastolic stunning","volume":"54","author":"Ishii","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2023.07.003_bb0225","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ejechocard\/jeq015","article-title":"Tissue Doppler echocardiography reveals distinct patterns of impaired myocardial velocities in different degrees of coronary artery disease","volume":"11","author":"Hoffmann","year":"2010","journal-title":"Eur J Echocardiogr"},{"issue":"6","key":"10.1016\/j.pcad.2023.07.003_bb0230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.amjmed.2018.12.038","article-title":"Heart failure with preserved ejection fraction: is ischemia due to coronary microvascular dysfunction a mechanistic factor?","volume":"132","author":"Elgendy","year":"2019","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.pcad.2023.07.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216240","article-title":"Overlap between angina without obstructive coronary artery disease and left ventricular diastolic dysfunction with preserved ejection fraction","volume":"14","author":"Michelsen","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pcad.2023.07.003_bb0240","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2023.07.003_bb0245","doi-asserted-by":"crossref","unstructured":"Lavie, C.J., et al., Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure, in JACC Heart Fail. 2013, \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc: United States. p. 93\u2013102.","DOI":"10.1016\/j.jchf.2013.01.006"},{"key":"10.1016\/j.pcad.2023.07.003_bb0250","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pcad.2022.11.013","article-title":"Updates on obesity and the obesity paradox in cardiovascular diseases","volume":"78","author":"Tutor","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.pcad.2023.07.003_bb0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11897-015-0257-5","article-title":"Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction","volume":"12","author":"Upadhya","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.pcad.2023.07.003_bb0260","author":"Prevention, C.f.D.C.a"},{"issue":"1","key":"10.1016\/j.pcad.2023.07.003_bb0265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2023.07.003_bb0270","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physrev.00017.2007","article-title":"Cardiac remodeling in obesity","volume":"88","author":"Abel","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pcad.2023.07.003_bb0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pcad.2023.05.003","article-title":"Heart failure and obesity: The latest pandemic","volume":"78","author":"Aryee","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.pcad.2023.07.003_bb0280","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/ejhf.1283","article-title":"Epicardial fat in heart failure patients with mid-range and preserved ejection fraction","volume":"20","author":"van Woerden","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.pcad.2023.07.003_bb0285","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diacare.18.5.708","article-title":"Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?","volume":"18","author":"Bell","year":"1995","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.pcad.2023.07.003_bb0290","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.pcad.2023.07.003_bb0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1006882805197","article-title":"Metabolic disturbances in diabetic cardiomyopathy","volume":"180","author":"Rodrigues","year":"1998","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"10.1016\/j.pcad.2023.07.003_bb0300","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: A unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.pcad.2023.07.003_bb0305","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jacc.2006.07.022","article-title":"Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy","volume":"48","author":"Cai","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0310","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","article-title":"Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"25","author":"Fang","year":"2004","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.pcad.2023.07.003_bb0315","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0008-6363(97)00010-2","article-title":"Regulation of intracellular Ca2+ in the heart during diabetes","volume":"34","author":"Pierce","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pcad.2023.07.003_bb0320","first-page":"151","article-title":"Predictors and prevention of diabetic cardiomyopathy","volume":"6","author":"Chavali","year":"2013","journal-title":"Diab Metab Syndr Obes"},{"issue":"6","key":"10.1016\/j.pcad.2023.07.003_bb0325","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","article-title":"Hyperglycemia-induced apoptosis in mouse myocardium: Mitochondrial cytochrome C-mediated caspase-3 activation pathway","volume":"51","author":"Cai","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.pcad.2023.07.003_bb0330","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5114\/aoms.2014.43748","article-title":"Heart failure in the diabetic population - pathophysiology, diagnosis and management","volume":"10","author":"Kasznicki","year":"2014","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.pcad.2023.07.003_bb0335","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00592-020-01600-x","article-title":"Functional capacity and left ventricular diastolic function in patients with type 2 diabetes","volume":"58","author":"Tadic","year":"2021","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.pcad.2023.07.003_bb0340","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12574-019-00446-9","article-title":"Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments","volume":"17","author":"Iwakura","year":"2019","journal-title":"J Echocardiogr"},{"issue":"1","key":"10.1016\/j.pcad.2023.07.003_bb0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.pcad.2023.07.003_bb0350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/heartjnl-2018-313234","article-title":"Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy","volume":"105","author":"Nadruz","year":"2019","journal-title":"Heart"},{"issue":"15","key":"10.1016\/j.pcad.2023.07.003_bb0355","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.116.025434","article-title":"Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast Cancer","volume":"135","author":"Saiki","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2023.07.003_bb0360","doi-asserted-by":"crossref","first-page":"H392","DOI":"10.1152\/ajpheart.00124.2017","article-title":"Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction","volume":"313","author":"Saiki","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.pcad.2023.07.003_bb0365","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1634\/theoncologist.2014-0299","article-title":"Diastolic dysfunction occurs early in HER2-positive breast cancer patients treated concurrently with radiation therapy and Trastuzumab","volume":"20","author":"Cao","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.pcad.2023.07.003_bb0370","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/9.suppl_E.57","article-title":"The natural history of aortic valve stenosis","author":"Horstkotte","year":"1988","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.pcad.2023.07.003_bb0375","first-page":"230","article-title":"Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology","volume":"28","author":"Vahanian","year":"2007","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.pcad.2023.07.003_bb0380","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cardfail.2017.05.002","article-title":"Increased left ventricular diastolic stiffness is associated with heart failure symptoms in aortic stenosis patients with preserved ejection fraction","volume":"23","author":"Kamimura","year":"2017","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.pcad.2023.07.003_bb0385","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCIMAGING.113.000636","article-title":"Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis","volume":"7","author":"Dahl","year":"2014","journal-title":"Circ Cardiovasc Imag"},{"issue":"2","key":"10.1016\/j.pcad.2023.07.003_bb0390","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jcmg.2012.10.013","article-title":"Hemodynamic patterns for symptomatic presentations of severe aortic stenosis","volume":"6","author":"Park","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"13","key":"10.1016\/j.pcad.2023.07.003_bb0395","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pcad.2023.07.003_bb0400","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.ASN.0000123691.46138.E2","article-title":"Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies","volume":"15","author":"Weiner","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.pcad.2023.07.003_bb0405","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.pcad.2023.07.003_bb0410","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/heartjnl-2016-310794","article-title":"Heart failure in patients with kidney disease","volume":"103","author":"Tuegel","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2023.07.003_bb0415","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2020.12.012","article-title":"The chronic kidney disease phenotype of HFpEF: Unique cardiac characteristics","volume":"142","author":"Kirkman","year":"2021","journal-title":"Am J Cardiol"},{"issue":"17","key":"10.1016\/j.pcad.2023.07.003_bb0420","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.jacc.2015.08.872","article-title":"Mitral annulus calcification","volume":"66","author":"Abramowitz","year":"2015","journal-title":"J Am Coll Cardiol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062023000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062023000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:22:02Z","timestamp":1758500522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062023000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":84,"alternative-id":["S0033062023000695"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2023.07.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into different phenotypic presentations of heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}